Home Markets IPO Lockup Expiration Alert: Nurix Therapeutics (NRIX)

IPO Lockup Expiration Alert: Nurix Therapeutics (NRIX)

3
investorsdiurnal business news magazine

This post was originally published on this site

(RTTNews) – The lockup period of San Francisco, California-based Nurix Therapeutics (NRIX) expires tomorrow , i.e., January 20, 2021.

Nurix Therapeutics is a biopharmaceutical company developing oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders.